ETF On Watch: PowerShares Dynamic Biotech & Genome ETF (PBE) Rises 0.45% for Nov 23

November 23, 2016 - By Dolores Ford   ·   0 Comments

Nov 23 is a positive day so far for PowerShares Dynamic Biotech & Genome ETF (NYSEARCA:PBE) as the ETF is active during the day after gaining 0.45% to hit $42.5 per share. The exchange traded fund has 247.21M net assets and 2.30% volatility this month.

Over the course of the day 4,465 shares traded hands, as compared to an average volume of 28,880 over the last 30 days for PowerShares Dynamic Biotech & Genome ETF (NYSEARCA:PBE).

The ETF is -16.63% of its 52-Week High and 26.72% of its low, and is currently having ATR of 1.14. This year’s performance is -14.67% while this quarter’s performance is 2.15%.

The ETF’s YTD performance is -25.98%, the 1 year is -24.77% and the 3 year is 2.64%.

The ETF’s average P/E ratio is 21.75, the price to book is 2.98, the price to sales is 5.2 and the price to cashflow is 9.45. It was started on 6/23/2005. The fund’s top holdings are: Incyte Corporation for 6.11% of assets, Alexion Pharmaceuticals Inc. for 5.69%, Gilead Sciences Inc. for 5.17%, Biogen Inc. for 5.14%, Regeneron Pharmaceuticals Inc. for 4.85%, BioMarin Pharmaceutical Inc. for 4.77%, Amgen Inc. for 4.67%, Vertex Pharmaceuticals Incorpor for 4.43%, Corcept Therapeutics Incorporat for 3.91%, Seattle Genetics Inc. for 3.61%. The ETF sector weights are: Healthcare 100.00%. The ETF currently as 0.91% yield.

More notable recent PowerShares Dynamic Biotech &Genome(ETF) (NYSEARCA:PBE) news were published by: Investorplace.com which released: “3 Biotech ETFs for Decades of Big Returns” on November 15, 2016, also Etftrends.com with their article: “You’re Missing out on a Super Software ETF” published on April 24, 2015, Zacks.com published: “Biotech ETF Industry Outlook” on August 31, 2016. More interesting news about PowerShares Dynamic Biotech &Genome(ETF) (NYSEARCA:PBE) were released by: Etftrends.com and their article: “Biotech Hedge Funds are hot, but Biotech ETFs are Hotter” published on May 29, 2015 as well as Etftrends.com‘s news article titled: “‘Tis the Season for Biotech ETFs” with publication date: January 05, 2015.

PowerShares Dynamic Biotechnology & Genome Portfolio is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The ETF has a market cap of $247.21 million. The Fund seeks investment results that correspond generally to the price and yield of the Index. It has a 3.27 P/E ratio. The Index consists of stocks of 30 the United States biotechnology and genome companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Dolores Ford


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>